Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit
04 August 2023 - 6:30AM
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on
reducing the risk of stroke and its devastating impact, today
announced the company will participate in the upcoming UBS MedTech,
Tools and Genomics Summit
.
Management is scheduled to present on Thursday, August 17,
2023 at 11:00 a.m. Pacific Time. Interested parties may
access a live and archived webcast of the presentation on the
“Investors” section of the company’s website
at: https://investors.silkroadmed.com/.
About Silk Road MedicalSilk Road Medical, Inc.
(NASDAQ: SILK), is a medical device company located in Sunnyvale,
California, and Plymouth, Minnesota, that is focused on reducing
the risk of stroke and its devastating impact. The company has
pioneered a new approach for the treatment of carotid artery
disease called TransCarotid Artery Revascularization (TCAR). TCAR
is a clinically proven procedure combining surgical principles of
neuroprotection with minimally invasive endovascular techniques to
treat blockages in the carotid artery at risk of causing a stroke.
For more information on how Silk Road Medical is delivering
brighter patient outcomes through brighter clinical thinking, visit
www.silkroadmed.com and connect on Twitter, LinkedIn and
Facebook.
Investor Contact:Lynn Lewis or Marissa
BychGilmartin Groupinvestors@silkroadmed.com
Silk Road Medical (NASDAQ:SILK)
Historical Stock Chart
From Apr 2024 to May 2024
Silk Road Medical (NASDAQ:SILK)
Historical Stock Chart
From May 2023 to May 2024